Jaime R. Merchan
- Obstetrics and Gynecology top 0.1%
- Molecular Biology top 5%
- Pulmonary and Respiratory Medicine top 1%
- Pediatrics, Perinatology and Child Health top 0.2%
- Oncology top 1%
- Co-authors
- Vikas P. SukhatmeS. Ananth KarumanchiJianyi LiIsaac E. StillmanTowia A. LibermannSharon E. MaynardFrank W. SellkeJames P. Morgan
- Topics
- Renal cell carcinoma treatment (33 papers)Pancreatic and Hepatic Oncology Research (22 papers)Virus-based gene therapy research (22 papers)
- Partner nations
- United StatesAustraliaCanada
In The Last Decade
Jaime R. Merchan
133 papers receiving 7.3k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Obstetrics and Gynecology 2.9k
- Molecular Biology 2.3k
- Pulmonary and Respiratory Medicine 2.1k
- Pediatrics, Perinatology and Child Health 2.1k
- Oncology 1.9k
Countries citing papers authored by Jaime R. Merchan
This map shows the geographic impact of Jaime R. Merchan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaime R. Merchan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaime R. Merchan more than expected).
Fields of papers citing papers by Jaime R. Merchan
This network shows the impact of papers produced by Jaime R. Merchan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaime R. Merchan. The network helps show where Jaime R. Merchan may publish in the future.
Co-authorship network of co-authors of Jaime R. Merchan
This figure shows the co-authorship network connecting the top 25 collaborators of Jaime R. Merchan. A scholar is included among the top collaborators of Jaime R. Merchan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jaime R. Merchan. Jaime R. Merchan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 7 | |
| 5 | 3 | |
| 6 | 9 | |
| 7 | 1 | |
| 8 | Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancerbreakdown → | 163 |
| 9 | 29 | |
| 10 | 5 | |
| 11 | Initial results of the phase 1 portion of an ongoing phase 1/2 study of RP1 as a single agent and in combination with nivolumab in patients with solid tumors | 1 |
| 12 | 28 | |
| 13 | 5 | |
| 14 | 25 | |
| 15 | Successful use of Trastuzumab with anthracycline-based chemotherapy followed by trastuzumab maintenance in patients with advanced HER2-positive gastric cancer. | 14 |
| 16 | 14 | |
| 17 | 94 | |
| 18 | 57 | |
| 19 | 60 | |
| 20 | 36 |
About Jaime R. Merchan
Jaime R. Merchan is a scholar working on Cancer Research, Oncology and Biotechnology, having authored 140 papers that have together received 7.4k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (33 papers), Pancreatic and Hepatic Oncology Research (22 papers) and Virus-based gene therapy research (22 papers). The work is most often cited by research in Obstetrics and Gynecology (2.9k citations), Pediatrics, Perinatology and Child Health (2.1k citations) and Cancer Research (1.5k citations). Jaime R. Merchan has collaborated with scholars based in United States, Australia and Canada. Frequent co-authors include Vikas P. Sukhatme, S. Ananth Karumanchi, Jianyi Li, Isaac E. Stillman, Towia A. Libermann, Sharon E. Maynard, Frank W. Sellke, James P. Morgan, Susanta Mondal and Franklin H. Epstein. Their work appears in journals such as JAMA, Journal of Clinical Investigation and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.